[Endobronchial prosthesis: experience report].

M Mohnke; L Freitag; D Greschuchna

Home/Archive/PubMed

PubMed · 1579563

[Endobronchial prosthesis: experience report].

M Mohnke·L Freitag·D Greschuchna

View original source ↗Export metadata ↓

Abstract

Between January 1988 and December 1990 a total of 84 endobronchial prosthesis were implanted in 55 patients at the Ruhrlandklinik, Essen. Bronchial carcinoma (33/55) was the leading indication for placing an endoluminal stent. Since the technique of implantation seldom leads to serious complications, non-malignant tracheobronchial stenosis and malacia play an increasing role in airway stenting. Implantation was usually performed under general anaesthesia and through rigid tube bronchoscopes with enlarged diameters. Most frequently a flexible silicone stent (Dumon) was used, Montgomery (5/84), Gianturco (5/84), Orlowski (4/84) and Strecker stents were also implanted. The respiratory gain was greatest in central stenosis, 79/84 stents were positioned into trachea or main stem bronchus. Permanent and temporary stenting were performed with success. Dislocation and hemoptysis seldom occur, mucus plugging and incrustation were more frequent complications.

Explore related subjects

Bronchi Bronchial Neoplasms Bronchography Carcinoma, Bronchogenic Carcinoma, Squamous Cell Evaluation Studies as Topic Follow-Up Studies Humans Lung Neoplasms Male Middle Aged Prostheses and Implants Stents Time Factors Trachea Tracheal Diseases Comparative Study English Abstract Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

M Mohnke, L Freitag, D Greschuchna. 1992. [Endobronchial prosthesis: experience report].. https://pubmed.ncbi.nlm.nih.gov/1579563/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

The cough reflex and its relation to gastroesophageal reflux.

Each cough involves a complex reflex arc beginning with the stimulation of sensory nerves that function as cough receptors. There is evidence, primarily clinical, that the sensory limb of the reflex exists in and outside of the lower respiratory tract. Although myelinated, rapidly adapting pulmonary stretch receptors (RARs), also known as irritant receptors, are the most likely type of sensory nerve that stimulates the cough center in the brain, afferent C-fibers and slowly adapting pulmonary stretch receptors (SARs) also may modulate cough. RARS, C-fibers, and SARs have been identified in the distal esophageal mucosa; however, studies have not been performed to determine whether they can participate in the cough reflex. Although gastroesophageal reflux disease can potentially stimulate the afferent limb of the cough reflex by irritating the upper respiratory tract without aspiration and by irritating the lower respiratory tract by micro- or macroaspiration, there is evidence that strongly suggests that reflux commonly provokes cough by stimulating an esophageal-bronchial reflex. Theoretically, the pathways of this reflex may be modeled in a variety of ways, and these are speculated upon in this article. The predominant role of acid in triggering cough by means of this reflex is unclear because of conflicting results from provocative challenge studies. It is interesting to speculate that a distal esophageal-bronchial reflex evolved as an early warning defense so that coughing could be started, just in case the refluxate were to reach the inlet of the lower respiratory tract. That is, thinking teleologically, it is possible that an esophageal-bronchial reflex evolved as one of several mechanisms designed to protect the lungs from aspiration of gastric contents.

Bronchi↗

PubMed2000

[Foreign body can be extracted by radiologic intervention technique. A case report with a successful extraction of a pivot tooth from peripheral bronchi].

Explore the source record for details and available documents.

Bronchi↗

PubMed2000

Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells.

Erythromycin (EM), and related 14-member macrolide antibiotics, has attracted attention for its effectiveness in airway diseases including diffuse panbronchiolitis and sinobronchial syndrome. However, its molecular mechanisms remain unknown. We evaluated the effects of EM on activation of several transcription factors, including nuclear factor-kappaB (NF-kappaB) and activator protein-1 (AP-1) in human bronchial epithelial cell line BET-1A, which are known to regulate the expression of many proinflammatory cytokines and chemokines such as interleukin-8 (IL-8). BET-1A cells were cultured with hormonally defined Ham's F12 medium, and were stimulated by phorbol myristate acetate (PMA). EM suppressed mRNA expression as well as the release of IL-8 at therapeutic and noncytotoxic concentrations (% inhibition of IL-8 protein release: 42.2 +/- 5.5%, at 10(-6) M). Furthermore, electrophoretic mobility shift assays revealed that EM inhibited the activations of NF-kappaB and AP-1 induced by PMA in BET-1A cells. These data indicate that EM has inhibitory effects not only on the mRNA expression and release of IL-8, but also on the activation of transcription factors NF-kappaB and AP-1. Our findings support the concept that the recruitment of neutrophils in airway diseases may be regulated by NF-kappaB and AP-1.

Bronchi↗